ArticleJournal of the American Pharmacists Association : JAPhA
Access to syringes at pharmacies (ASAP): Preliminary impact of a pharmacy-level intervention.
Article in Journal of the American Pharmacists Association : JAPhA. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundCommunity pharmacies are important access points for services to reduce bloodborne illnesses (BBIs) like HIV and Hepatitis C. However multiple barriers limit pharmacy provision of these services, including stigma toward people who use drugs (PWUD) and staff discomfort with harm reduction practices.
objectiveThis study evaluated a pharmacy-level intervention called Access to Syringes at Pharmacies (ASAP) designed to increase nonprescription syringe sales and reduce stigma.
methodsA one-armed pilot study was conducted with 18 staff of 3 community pharmacies located in 3 different Arizona counties from January to April 2022. Data were collected through monthly surveys measuring staff comfort with selected harm reduction practices and stigma toward PWUD. Ecological momentary assessment tracked dispensing behaviors. Linear mixed effects models with bootstrapping analyzed changes over time.
resultsAll 3 pharmacies reported selling syringes without a prescription during the study period, with variation in number of sales events between the pharmacies. The number of pharmacy staff who reported "always" dispensing syringes without a prescription increased from 44.4% at baseline to 77.8% by study end. Comfort with harm reduction practices increased significantly immediately following training (β = 0.39). Stigma scores decreased significantly both immediately post-training (β = -0.41) and at study end (β = -0.34). Throughout the intervention, higher stigma scores were consistently associated with lower likelihood of syringe dispensing (r > -0.45).
conclusionsThe ASAP intervention provides reason for optimism for effective pharmacy-based education to increase nonstigmatized syringe dispensing to reduce BBIs and infections. Future studies should evaluate ASAP in a larger, controlled trial across diverse pharmacy settings to establish causal relationships and optimize implementation strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.